Japan’s Takeda Pharma says full-year profit slid 9.5%
15:24 JST, May 11, 2022
TOKYO (Reuters) – Takeda Pharmaceutical Co said on Wednesday that 12-month operating profit slid 9.5% from the previous year.
Operating profit for Japan’s largest drugmaker in the year that ended on March 31 came in at 461 billion yen ($3.54 billion).
That compares with its own earlier estimate of 515 billion yen and a consensus forecast of 509 billion yen from a Refinitiv poll of 15 analysts.
The company estimated the current fiscal year’s operating profit will rise to 520 billion yen.
($1 = 130.3700 yen)
"News Services" POPULAR ARTICLE
-
Executives at Japan’s Fuji TV and Parent Firm Resign over a Sex Scandal Linked to a Former Star
-
Magnitude 6.9 Earthquake Rattles Southwestern Japan, Followed by Tsunami Warnings
-
Japan’s Nikkei Stock Logs Worst Day in 4 Months on US Tariff Worries; Automakers Slump (UPDATE 2)
-
Japan’s Nikkei Stock Falls over 1% as Chip-Related Shares Track Nasdaq Lower (UPDATE 1)
-
Israel Says Truce with Hamas Begins, after Delay
JN ACCESS RANKING